There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Align Tech (ALGN – Research Report), Amarin (AMRN – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments. Align Tech (ALGN) Robert W. Baird analyst Jeff Johnson maintained a Buy rating on Align Tech on April 13 and set a price target of $625.00. The company's shares closed last Thursday at $409.82, close to its 52-week low of $372.62. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-align-tech-algn-amarin-amrn?utm_source=advfn.com&utm_medium=referral
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Amarin Charts.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Amarin Charts.